AIM: To identify factors predicting the clinical response of ulcerative colitis patients to
granulocyte-monocyte apheresis (GMA). METHODS: Sixty-nine ulcerative colitis patients (39 …

OBJECTIVE Leukocytapheresis (LCAP) is a method of therapeutic apheresis that removes
peripheral leukocytes. Previous studies showed that in patients with ulcerative colitis (UC) …

Leukocytapheresis, device used to remove leukocytes from peripheral circulation, has been
approved for the treatment of active ulcerative colitis (UC) by the Ministry of Health and …

Recently, successful results of ulcerative colitis (UC) treatments with leukocyte apheresis
have been reported by several institutes. To certify the efficacy of leukocyte apheresis in …

Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive
aphaeresis in active ulcerative colitis pati Page 1 3. Agrawal A, Houghton LA, Morris J, et al …

Objective The goal of treatment in ulcerative colitis (UC) is to induce and maintain remission.
The addition of granulocyte and monocyte apheresis (GMA) to conventional therapy may be …

Ulcerative colitis (UC) and Crohn's disease (CD) are the major forms of idiopathic
inflammatory bowel disease (IBD). Both UC and CD are debilitating chronic disorders that …

AIM: To investigate efficacy and safety for granulocyte, monocyte apheresis in a population
of pediatric patients with ulcerative colitis. METHODS: The ADAPT study was a prospective …

Background Patients with ulcerative colitis (UC) have elevated/activated myeloid lineage
leucocytes and may respond favorably to adsorptive granulocyte/monocyte apheresis …

Granulocyte-monocyte apheresis is a relatively new therapy that has been proposed,
sometimes with controversial results, for the treatment of inflammatory bowel disease …